Who Exports Lactulose from India — 154 Suppliers Behind a $13.4M Market
India's lactulose export market is supplied by 154 active exporters who collectively shipped $13.4M across 956 shipments. STERLING LAB, leads with a 31.0% market share, followed by LINCOLN PHARMACEUTICALS LTD and PANACEA BIOTEC PHARMA LIMITED. The top 5 suppliers together control 67.3% of total export value, reflecting a concentrated market structure.
Top Lactulose Exporters from India — Ranked by Export Value
STERLING LAB, is the leading lactulose exporter from India, holding a 31.0% share of the $13.4M market across 956 shipments from 154 exporters. The top 5 suppliers — STERLING LAB,, LINCOLN PHARMACEUTICALS LTD, PANACEA BIOTEC PHARMA LIMITED, SANPRAS HEALTHCARE PRIVATE LIMITED, CAPLIN POINT LABORATORIES LIMITED — collectively control 67.3% of total export value, indicating a moderately concentrated market. Individual shares are: STERLING LAB, (31.0%), LINCOLN PHARMACEUTICALS LTD (13.7%), PANACEA BIOTEC PHARMA LIMITED (9.0%), SANPRAS HEALTHCARE PRIVATE LIMITED (8.0%), CAPLIN POINT LABORATORIES LIMITED (5.7%).
Top Lactulose Exporters from India
Ranked by export value · 154 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | STERLING LAB, ECOLAC SOLUTION(LACTULOSE SOLUTION USP 3LAXIRIGHT (LACTULOSE SOLUTION USP 10G/15LACTULOSE SOLUTION USP 10G/15ML BATCH N | $4.2M | 1 | 31.0% |
| 2 | LINCOLN PHARMACEUTICALS LTD LACTULOSE SOLUTION USP 3.35 GM/ 5 ML (LARAPIDUCE LACTULOSE SOLU USP 100 MLHARMLESS MEDICINE - LACTULOSE SOLUTION USP UNIT : 100 ML | $1.8M | 7 | 13.7% |
| 3 | PANACEA BIOTEC PHARMA LIMITED ECOLAC SOLUTION(LACTULOSE SOLUTION USP 3LACTULOSE SOLUTION USP 3.35 GM/ 5 ML (LALAXIRIGHT (LACTULOSE SOLUTION USP 10G/15 | $1.2M | 11 | 9.0% |
| 4 | SANPRAS HEALTHCARE PRIVATE LIMITED LACTULOSE SOLUTION USP 3.335G/5MLLACTULOSE SOLUTION USP 200ML X 24 (MFG DLACTULOSE SOLUTION USP 200ML X 24 BATCH | $1.1M | 2 | 8.0% |
| 5 | CAPLIN POINT LABORATORIES LIMITED LACTULOSE SOLUTION USP 3.335G/5MLLACTULOSE SOLUTION USP 200ML X 24 (MFG DLACTULOSE SOLUTION USP 200ML X 24 BATCH | $763.1K | 3 | 5.7% |
| 6 | MERCURY LABORATORIES LIMITED LACTULOSE SOLUTIONLACTULOSE SOLUTION USP 3.335G/5MLLACTULOSE SOLUTION USP 3.335 G /5 ML | $321.4K | 2 | 2.4% |
| 7 | ASMOH LABORATORIES LIMITED LACTULOSE SOLUTIONLACTULOSE SOLUTION USP 3.335G/5MLLACTULOSE SOLUTION USP 3.335 G /5 ML | $310.4K | 3 | 2.3% |
| 8 | ALVITA PHARMA PRIVATE LIMITED ECOLAC SOLUTION(LACTULOSE SOLUTION USP 3LAXIRIGHT (LACTULOSE SOLUTION USP 10G/15LACTULOSE SOLUTION USP 10G/15ML BATCH N | $243.0K | 3 | 1.8% |
| 9 | MAGBRO HEALTH CARE PRIVATE LIMITED LACTOBURG(LACTULOSE SOLUTION USP 10GM/15EASY LAC LACTULOSE SOLUTION 3.35 G/5 MLDOLAC BT#LE2405025 MFG#MAY-2024 EXP#APRIL-202624900NOS | $191.4K | 1 | 1.4% |
| 10 | BHARAT PARENTERALS LIMITED LACTULOSE SOLUTION USP CONSTISTOP 1X300ML BOTTLELACTULOSE SOLUTION USP CONSTISTOP UNIT PACK 1X300ML BOTTLELACTULOSE SOLUTION USP CONSTISTOP 1X150ML BOTTLE | $171.8K | 1 | 1.3% |
| 11 | S K AGE EXPORTS ECOLAC SOLUTION(LACTULOSE SOLUTION USP 3LACTULOSE SOLUTION USP 3.35 GM/ 5 ML (LALACTULOSE SOLUTION USP 3.335G/5ML | $142.7K | 4 | 1.1% |
| 12 | SANPRAS HEALTHCARE PVT LTD LACTULOSE SOLUTION USP 3.335G/5MLLACTULOSE SOLUTION USP 200ML X 24 (MFG DLACTULOSE SOLUTION USP 200ML X 24 BATCH | $131.8K | 1 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Lactulose exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Lincoln Pharmaceuticals Limited | Not Listed | Yes, certified in 19 | Yes, certified | Not verified | Manufacturing facilities certified by WHO-GMP and EU-GMP. |
| Panacea Biotec Pharma Limited | Not Listed | Yes, certified in 20 | Not Listed | Not verified | WHO-GMP certification obtained in 2007. |
| Sterling Lab | Not Listed | Yes | Not Listed | Not verified | Listed as WHO-GMP certified. |
| S. Kant Healthcare Ltd. | Not Listed | Yes | Not Listed | Not verified | Listed as WHO-GMP certified. |
| Skant Healthcare Ltd. | Not Listed | Yes | Not Listed | Not verified | Listed as WHO-GMP certified. |
TransData Nexus reviewed the regulatory standing of 5 leading Lactulose exporters from India. 0 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Lactulose sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes to over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in the production of Active Pharmaceutical Ingredients (APIs) and intermediates. For instance, A.R. Life Sciences, established in 2007, manufactures a wide range of APIs and intermediates, adhering to Good Manufacturing Practices (GMP) and holding ISO 9001:2015 certification. This robust infrastructure positions Hyderabad as a pivotal hub for sourcing bulk drugs like Lactulose.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Vadodara, in particular, is home to numerous pharmaceutical companies specializing in the production of formulations and biogenerics. (mediaindia.eu) Companies like Ester Formulations, located near Vadodara, manufacture a comprehensive range of pharmaceutical formulations, including tablets, capsules, oral liquids, and injectables. This specialization makes the region a strategic choice for sourcing finished Lactulose products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to various international markets. Companies like Formel Labs, with facilities in both Mumbai and Hyderabad, leverage this strategic location to manufacture and export high-quality pharmaceuticals, including bulk drugs and formulations. The region's well-established logistics and regulatory infrastructure support efficient international distribution of products like Lactulose.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, primarily due to favorable tax incentives. This zone attracts numerous pharmaceutical companies seeking cost-effective production solutions. While specific data on Lactulose production in this region is limited, the overall manufacturing capabilities make it a potential area for sourcing various pharmaceutical products.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Certifications: Prioritize suppliers with GMP, ISO, and other relevant certifications to ensure product quality and regulatory compliance.
- Assess Export Capabilities: Partner with suppliers in regions like Mumbai-Thane-Raigad that have established export infrastructures to facilitate efficient international distribution.
- Monitor Regulatory Changes: Stay informed about regional tax incentives and regulatory policies, especially in zones like Baddi-Nalagarh, to optimize sourcing strategies.
By strategically leveraging the strengths of India's pharmaceutical clusters, companies can effectively source Lactulose and other pharmaceutical products to meet global demand.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Lactulose exporters from India
Caplin Point Laboratories Limited — Caplin acquires 10 approved ANDAs for injectables and ophthalmic products
Caplin Point Laboratories Limited, through its subsidiaries Caplin Steriles Limited and Caplin One Labs Limited, acquired 10 approved Abbreviated New Drug Applications (ANDAs) for injectable and ophthalmic products from a leading multinational generic product manufacturing company. The addressable market for these products was $473.2 million for the 12-month period ending August 2025. - IMPACT: This acquisition is expected to enhance Caplin's product portfolio, potentially increasing its Lactulose export capabilities.
Impact: This acquisition is expected to enhance Caplin's product portfolio, potentially increasing its Lactulose export capabilities.
Caplin Point Laboratories Limited — Caplin receives USFDA approval for Nicardipine Hydrochloride injection
Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories Limited, received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection. - IMPACT: This approval may bolster Caplin's regulatory standing, potentially facilitating increased Lactulose exports.
Impact: This approval may bolster Caplin's regulatory standing, potentially facilitating increased Lactulose exports.
Caplin Point Laboratories Limited — Caplin Steriles receives Establishment Inspection Report from USFDA
Caplin Steriles Limited received an Establishment Inspection Report (EIR) from the USFDA with a satisfactory outcome, indicating compliance with regulatory standards. - IMPACT: This compliance may enhance Caplin's credibility, potentially leading to increased Lactulose exports.
Impact: This compliance may enhance Caplin's credibility, potentially leading to increased Lactulose exports.
Common Questions — Lactulose Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which lactulose supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, STERLING LAB, leads with 19 recorded shipments worth $4.2M. LINCOLN PHARMACEUTICALS LTD (14 shipments) and PANACEA BIOTEC PHARMA LIMITED (47 shipments) are also established high-volume exporters.
Q How many lactulose manufacturers are there in India?
India has 154 active lactulose exporters with a combined export market of $13.4M across 956 shipments to 90 countries. The top 5 suppliers hold 67.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for lactulose from India?
Average FOB unit price: $2.84 per unit, ranging from $0.01 to $83.86. Average shipment value: $14.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 154 verified Indian exporters of Lactulose ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 956 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 90 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
956 Verified Shipments
154 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists